CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.
Jin HS, Ko M, Choi DS, Kim JH, Lee DH, Kang SH, Kim I, Lee HJ, Choi EK, Kim KP, Yoo C, Park Y.
Jin HS, et al. Among authors: park y.
Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7.
Cancer Immunol Res. 2020.
PMID: 32265229